Regeneron Pharmaceuticals
REGN
#294
Rank
NZ$107.96 B
Marketcap
$987.53
Share price
0.40%
Change (1 day)
-35.55%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): NZ$7.89 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.20 Billion. , an increase over its 2023 earnings that were of NZ$7.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 NZ$8.02 B13.83%
2023 NZ$7.05 B-13.57%
2022 NZ$8.16 B-47.9%
2021 NZ$15.66 B144.75%
2020 NZ$6.40 B56.86%
2019 NZ$4.08 B-4.87%
2018 NZ$4.28 B22.86%
2017 NZ$3.49 B56.3%
2016 NZ$2.23 B8.55%
2015 NZ$2.05 B54.53%
2014 NZ$1.33 B11.14%
2013 NZ$1.19 B72.13%
2012 NZ$0.69 B-285.93%
2011 -NZ$0.38 Billion121.73%
2010 -NZ$0.17 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.20 B2103.7%
2004 NZ$9.48 M-105.66%
2003 -NZ$0.17 Billion-18.18%
2002 -NZ$0.21 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$62.76 Million51.87%
1999 -NZ$41.33 Million92.19%
1998 -NZ$21.51 Million66.23%
1997 -NZ$12.94 Million-55.49%
1996 -NZ$29.07 Million103.53%
1995 -NZ$14.28 Million-70.89%
1994 -NZ$49.06 Million-26.08%
1993 -NZ$66.36 Million114.67%
1992 -NZ$30.92 Million196.77%
1991 -NZ$10.42 Million87.88%
1990 -NZ$5.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.74 B-3.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.4 Billion-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.20 B-60.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.30 B 264.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.91 B 185.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$13.34 B 66.15%๐Ÿ‡ซ๐Ÿ‡ท France